Attached files
| file | filename |
|---|---|
| EX-23.1 - EX-23.1 - IDERA PHARMACEUTICALS, INC. | b84116exv23w1.htm |
| EX-31.2 - EX-31.2 - IDERA PHARMACEUTICALS, INC. | b84116exv31w2.htm |
| EX-32.1 - EX-32.1 - IDERA PHARMACEUTICALS, INC. | b84116exv32w1.htm |
| EX-32.2 - EX-32.2 - IDERA PHARMACEUTICALS, INC. | b84116exv32w2.htm |
| EX-31.1 - EX-31.1 - IDERA PHARMACEUTICALS, INC. | b84116exv31w1.htm |
| EX-10.14 - EX-10.14 - IDERA PHARMACEUTICALS, INC. | b84116exv10w14.htm |
| 10-K - IDERA PHARMACEUTICALS, INC. - IDERA PHARMACEUTICALS, INC. | b84116e10vk.htm |
Exhibit 10.41
Director Compensation Program
Effective July 1, 2010
Effective July 1, 2010
Under our director compensation program, we pay our non-employee directors retainers in cash.
Each director receives a cash retainer for service on the board of directors and for service on
each committee on which the director is a member. These fees are payable quarterly in arrears and
are as follows:
Cash Fees
| Member | Chairman | |||||||
| Annual Fee | Annual Fee | |||||||
Board of Directors |
$ | 35,000 | — | |||||
Audit Committee |
$ | 7,000 | $ | 15,000 | ||||
Compensation Committee |
$ | 7,000 | $ | 15,000 | ||||
Nominating and Corporate Governance Committee |
$ | 3,500 | $ | 7,500 | ||||
Scientific Committee |
$ | 3,500 | $ | 7,500 | ||||
The Lead Director of the Board of Directors receives an annual fee of $52,500.
Equity Fees
Our director compensation program also includes a stock-for-fees policy, under which directors
have the right to elect to receive common stock in lieu of cash fees. The number of shares to be
issued to participating directors is determined on a quarterly basis by dividing the cash fees to
be issued in common stock by the fair market value of our common stock, which is the closing price
of our common stock, on the first business day of the quarter following the quarter in which the
fees were earned.
Under our director compensation program, upon their initial election to the board of
directors, new non-employee directors receive an option grant for 16,000 shares and all
non-employee directors receive an annual option grant for 10,000 shares. The annual grants are made
on the date of the annual meeting of stockholders. These options vest quarterly over three years
from the date of grant, subject to continued service as a director, and are granted under our 2008
Stock Incentive Plan. These options are granted with exercise prices equal to the fair market value
of our common stock, which is the closing price of our common stock, on the date of grant and
become immediately exercisable in full if there is a change in control of our company.